Biostar Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense
Biostar Pharmaceuticals, Inc. reported Share-based Payment Arrangement, Expense of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-04-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2016-04-14
- Biostar Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2014-12-31 was $1.32M.
- Biostar Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2014-09-30 was $99.55K.
- Biostar Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2014-06-30 was -$3.63M.
- Biostar Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2014-03-31 was $3.86M.
- Biostar Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- Biostar Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2014 was $1.66M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-04-14 | |||
| 2014-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | $1.42M derived: sum of 2 quarters · filed 2016-04-14 | -$2.21M derived: sum of 3 quarters · filed 2016-04-14 | $1.66M 10-K · filed 2016-04-14 |
| 2014-09-30 | $99.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$3.53M derived: sum of 2 quarters · filed 2014-11-14 | $331.83K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$3.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $232.28K 10-Q · filed 2014-08-14 | ||
| 2014-03-31 | $3.86M 10-Q · filed 2014-05-15 |